〰️
Congrats to Anlan Hong on his ACS Sensors manuscript (Dec 2025).
〰️
Congrats to Keyu Zhuang on her Magn Reson Med manuscript (Feb 2026).
〰️
Congrats to Sajida Chowdhury on her Connaught PhD Public Impact Fellowship (April 2026).
〰️
Congrats to Kaiwen Liu on his CGSR-D doctoral scholarship (May 2026).
〰️
Congrats to Dr. Anlan Hong on his PhD defense (June 2026)!
〰️ Congrats to Anlan Hong on his ACS Sensors manuscript (Dec 2025). 〰️ Congrats to Keyu Zhuang on her Magn Reson Med manuscript (Feb 2026). 〰️ Congrats to Sajida Chowdhury on her Connaught PhD Public Impact Fellowship (April 2026). 〰️ Congrats to Kaiwen Liu on his CGSR-D doctoral scholarship (May 2026). 〰️ Congrats to Dr. Anlan Hong on his PhD defense (June 2026)!
ABOUT US
Research in the Cheng laboratory is focused on the development of non-gadolinium contrast agents and quantitative magnetic resonance imaging technology to enable early detection of cardiovascular diseases and to guide new stem cell and tissue engineering therapeutics. We take imaging beyond its role as an anatomical tool and advance it to probe dynamic events at a physiological, cellular, and molecular level. An important philosophy at the heart of our research is translation to patients – hence, our emphasis on faithful animal models of human disease, rapid imaging capabilities, and new contrast agents with a safer toxicity profile than the clinical standard.
